[EN] COMBINATION THERAPY FOR THE TREATMENT OF CANCER USING COX-2 INHIBITORS AND DUAL INHIBITORS OF EGFR [ERBB1] AND HER-2 [ERBB2]<br/>[FR] POLYTHÉRAPIE POUR LE TRAITEMENT DE CANCER AU MOYEN D'INHIBITEURS DE LA COX-2 ET D'INHIBITEURS DOUBLES DE L'EGFR [ERBB1] ET DE L'HER-2 [ERBB2]
申请人:TRAGARA PHARMACEUTICALS INC
公开号:WO2009042613A1
公开(公告)日:2009-04-02
Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
本文描述了一种用于治疗癌症、肿瘤和肿瘤相关疾病的组合物和使用这些组合物的方法。
THERAPIES FOR TREATING CANCER USING COMBINATIONS OF COX-2 INHIBITORS AND AROMATASE INHIBITORS OR COMBINATIONS OF COX-2 INHIBITORS AND ESTROGEN RECEPTOR ANTAGONISTS
申请人:Estok Thomas M.
公开号:US20120015919A1
公开(公告)日:2012-01-19
Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
本文描述了一种组合物和使用这些组合物治疗受体中的癌症、肿瘤和肿瘤相关疾病的方法。
Use of cyclooxygenase-2 inhibitors for the treatment and prevention of tumors, tumor-related disorders and cachexia
申请人:Sankyo Company Limited
公开号:EP0927555A1
公开(公告)日:1999-07-07
Certain cyclooxygenase-2 inhibitors are useful for the treatment and prevention of tumours and tumour-related disorders and cachexia.